Summer is officially here, and psychedelic researchers are continuing their efforts to turn these medicines into viable therapy options. Despite relatively few clinical trials published in June, we’re continuing to learn more about the effects of psychedelics through the reanalysis of existing datasets and surveys. Moreover, researchers continue to hypothesise how psychedelics work on the brain…

Source

Previous articleFILAMENT HEALTH ANNOUNCES FIRST DOSING IN GROUNDBREAKING FDA-APPROVED PSILOCIN CLINICAL TRIAL
Next articleAlgernon Pharmaceuticals Provides Update on its Planned Phase 1 Repirinast Chronic Kidney Disease Study